Developing a new imaging system to guide medical procedures using sound and light.
Real-time spectroscopic photoacoustic/ultrasound (PAUS) scanner withsimultaneous fluence and motion compensation to guide and validateinterventions: system development and preclinical testing.
This study is testing a new imaging system that uses light and sound to help doctors see important details about your tissues, like blood oxygen levels, during treatments, making procedures like ethanol ablation more effective and precise.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-10889089 on NIH RePORTER |
What this research studies
This research aims to create a real-time imaging system that combines photoacoustic and ultrasound technologies to enhance the guidance of medical interventions. By using a specialized laser and advanced imaging techniques, the system can visualize and quantify tissue characteristics, such as blood oxygen levels, during procedures. This innovative approach includes automatic adjustments for laser intensity and patient movement, ensuring accurate imaging. The goal is to improve the effectiveness of interventions, particularly in therapies like ethanol ablation.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients undergoing interventional procedures that could benefit from enhanced imaging guidance.
Not a fit: Patients not undergoing any interventional procedures or those with conditions unrelated to the imaging techniques being developed may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more precise and effective medical interventions, improving patient outcomes.
How similar studies have performed: Other research has shown promise in using similar imaging techniques for medical interventions, indicating potential for success in this novel approach.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: O'donnell, Matthew — University of Washington
- Study coordinator: O'donnell, Matthew
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.